Q: What does AI medical negligence UK mean in this article? A: AI medical negligence UK refers to legal claims in the UK arising when patients are harmed because of errors made by AI tools used in healthcare. Under the current law, clinicians and the NHS can still be held liable even if an algorithm produced the error, according to the Medical Protection Society. Q: Who could be sued if an AI tool makes a mistake in NHS care? A: AI medical negligence UK claims could be brought against doctors and NHS organisations even when an AI tool contributed to an error, the article warns. The MPS says clinicians risk becoming a “liability sink” unless the law is changed and NHS Resolution is drafting guidance on AI liability. Q: What legal reform does the Medical Protection Society recommend? A: The MPS recommends reclassifying AI tools as products under the Consumer Protection Act 1987 so developers and manufacturers can be held responsible when technology fails. It says this change would help prevent AI medical negligence UK claims from falling solely on clinicians and the NHS. Q: What practical steps can clinicians take now to reduce the risk of AI-related liability? A: To reduce the risk of AI medical negligence UK claims, clinicians should keep a human in the loop, verify AI outputs before changing diagnosis or treatment, and document the tool name, version, inputs, outputs and final judgment. They should also validate tools locally, inform patients about AI use, set escalation rules for high-risk findings, and engage insurers and indemnity providers early. Q: What clinical examples illustrate how AI errors could cause harm? A: The article gives two examples: an AI missing a small lung tumour on a chest X-ray, which could delay treatment and worsen outcomes, and an AI wrongly recommending a higher warfarin dose that could cause severe bleeding and ICU care. These scenarios are cited as typical risks that could trigger AI medical negligence UK claims if governance is weak. Q: Are there any national guidelines or protections being developed to address AI liability? A: NHS Resolution is drafting guidance on AI liability and the Department of Health and Social Care says it will review the MPS report and recommendations. However, the article notes that until law and regulation catch up, providers must use governance and safer workflows to limit AI medical negligence UK risk. Q: What should hospital leaders do to manage AI tools and limit legal exposure? A: Leaders should map their AI inventory, assign a responsible clinician and data lead for each tool, add AI to the risk register with clear metrics and stop criteria, and standardise patient messaging about AI use. They should also align contracts with indemnity and safety reporting requirements, monitor performance in real time, and share learning across departments to reduce AI medical negligence UK risk. Q: How should procurement and vendor contracts be handled to protect patients and clinicians? A: Procurement should demand performance evidence, appropriate UKCA/CE marking where needed, uptime and security SLAs, and vendor indemnities or liability terms before deployment. Contracts should also require controlled update procedures, re-validation after changes, and evidence of security testing to reduce the chance of AI medical negligence UK incidents.